Yuqing Zhang

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Endothelial Cells

Replacement Therapy

Acute Myeloid Leukemia

Transforming Growth Factor

Top Venues

Cancer research

EMBO molecular medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqing Zhang, Rolf A Brekken
Are TEMs Canceled? Questioning the Functional Relevance of Tie2-Expressing Macrophages. Cancer research 82 (7) (2022)
Yuqing Zhang, Morgan Coleman, Rolf A Brekken
Perspectives on Hypoxia Signaling in Tumor Stroma. Cancers 13 (12) (2021)
Yuqing Zhang, Emily N Arner, Ali Rizvi, Jason E Toombs, Huocong Huang, Steven L Warner, Jason M Foulks, Rolf A Brekken
AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Molecular cancer therapeutics (2021)
Huocong Huang, Yuqing Zhang, Valerie Gallegos, Noah Sorrelle, Mohamed Medhat Zaid, Jason Toombs, Wenting Du, Steven Wright, Moriah Hagopian, Zhaoning Wang, Abdel Nasser Hosein, Adwait Amod Sathe, Chao Xing, Eugene J Koay, Kyla E Driscoll, Rolf A Brekken
Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. EMBO molecular medicine 11 (11) (2019)